Racial differences in the incidence of End-Stage Renal Disease

Ethnicity and Health

Volumn 1, Issue 1, 1996, Pages 21-31

  Tell, Grethe S ^a   Hylander, Britta ^b   Craven, Timothy E ^c   Burkart, John ^c  

^a UNIVERSITY OF BERGEN   (Norway)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; End stage renal disease; Ethnicity; Hypertension; Kidney disease; Race

Indexed keywords

DISEASE INCIDENCE; END-STAGE RENAL DISEASE; KIDNEY DISEASE; MEDICAL GEOGRAPHY; RACIAL DISPARITY;

ADOLESCENT; ADULT; AGED; ARTICLE; CAUCASIAN; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; ETHNOLOGY; FEMALE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NEGRO; RENOVASCULAR HYPERTENSION; RETROSPECTIVE STUDY; RISK; UNITED STATES;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPERTENSION, RENAL; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NORTH CAROLINA; ODDS RATIO; RETROSPECTIVE STUDIES; RISK;

USA, NORTH CAROLINA, FORSYTH COUNTY;

EID: 0030093119     PISSN: 13557858     EISSN: None     Source Type: Journal    
DOI: 10.1080/13557858.1996.9961767     Document Type: Article

References (57)

1. US Renal Data System, USRDS 1993 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, March 1993.
2. Mausner J, Kramer S, Mausner and Bahn. Epidemiology - An Introductory Text. WB Saunders, Philadelphia 1985; (2nd Edition), pp. 339-41.
3. Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research, principles and quantitative methods. Van Nostrand Reinhold, New York, 1982.
4. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks. JAMA 1992; 268: 3079-84.
5. US Renal Data System, USRDS 1989 Annual Data Report, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, August 1989.
6. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive ESRD are not entirely explained by differences in prevalence of hypertension. Am J Kid Dis 1988; 12: 285-90.
7. Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 1991; 151: 1359-64.
8. Ferguson R, Grim CE, Opgenorth TJ. A familial risk of chronic renal failure among blacks on dialysis? J Clin Epidemiol 1988; 41: 1189-96.
9. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM. The familial risk of end-stage renal disease in African-Americans. Am J Kidney Dis 1993; 21: 387-93.
10. Hoy WE, Megill DM, Hughson MD. Epidemic renal disease of unknown etiology in the Zuni Indians. Am J Kidney Dis 1987; 9: 485-96.
11. Whelton PK, Klag MJ. Hypertension as a risk factor for renal disease. Hypertension 1989; 13 (Suppl. 1): 119-127.
12. Perneger TV, Klag MJ, Feldman HI, Whelton PK. Projections of hypertension-related renal disease in middle-aged residents of the United States. JAMA 1993; 269: 1272-7.
13. Levy SB, Talner LB, Coel MN. Renal vasculature in essential hypertension: racial differences. Ann Intern Med 1978; 88: 12-6.
14. Frohlich ED, Messerli FH, Dunn FG. Greater renal vascular involvement in the black patient with essential hypertension. Miner Electrolyte Metab 1984; 10: 173-7.
15. Sowers JR, Zemel MB, Zemel P, Beck FW, Walsh MF, Zawada ET. Salt sensitivity in blacks. Salt intake and natriuretic substances. Hypertension 1988; 12: 485-90.
16. Lilley JJ, Hsu L, Stone RA. Racial disparity of plasma volume in hypertensive man. Ann Intern Med 1976; 84: 707-8.
17. Levy SB, Lilley JJ, Frigon RP, Stone RA. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake. J Clin Invest 1977; 60: 129-38.
18. Hypertension Detection and Follow Up Program Cooperative Group. Blood pressure studies in 14 communities. JAMA 1977; 237: 238-91.
19. Brazy PC, Fitzwilliam JF. Progressive renal disease: role of race and antihypertensive medications. Kidney Intern 1990; 37: 1113-9.
20. Flack JM, Neaton JD, Daniels B, Esunge P. ethnicity and renal disease: Lessons from the Multiple Risk Factor Intervention Trial and the Treatment of Mild Hypertension Study. Am J Kidney Dis 1993; 21 (Suppl. 1): 31-40.
21. FitzSimmons SC, Agodoa L, Striker L, Conti F, Striker G. Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and prevention. Am J Kidney Dis 1989; 13: 7-10.
22. Eggers PW, Connerton R, McMullan M. The Medicare experience with end-stage renal disease: trends in incidence, prevalence and survival. Health Care Financ Rev 1984; 5: 69-88.
23. Stephens GW, Gillaspy JA, Clyne D, Mejia A, Pollak VE. Racial differences in the incidence of end-stage renal disease in types I and II diabetes mellitus. Am J Kidney Dis 1990; 15: 562-7.
24. Kappel DF, Van Tuinen M. Trends in the incidence of treated end-stage renal disease secondary to diabetic nephropathy: 1975-84. Am J Kidney Dis 1986; 8: 234-8.
25. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic, end-stage renal disease according to race and type of diabetes. N Engl J Med 1989; 321: 1074-9.
26. Humphrey LL, Ballard DJ, Frohnert PP, Chu CP, O'Fallon WM, Palumbo PJ. Chronic renal failure in non-insulin-dependent diabetes mellitus. Ann Intern Med 1989; 111: 788-96.
27. Rostand SG. Letter. N Engl J Med 1989; 321: 1121-2.
28. Eberhardt MS, Lackland DT, Wheeler FC, Teutsch SM. Glycemic control in blacks and whites with diabetes in two South Carolina communities. Diabetes 1990; 39 (Suppl. 1): 205A.
29. Tierney WM, McDonald CJ, Luft FC. Renal disease in hypertensive adults: effect of race and type II diabetes mellitus. Am J Kidney Dis 1989; 13: 485-93.
30. Rewers M, Wagenknecht L, Watanabe RM. Insulin sensitivity in non-diabetic blacks, Hispanics and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetes 1994; 43 (Suppl. 1): 151A.
31. Lebovitz HE, Palmisano J. Cross-sectional analysis of renal function in black Americans with NIDDM. Diabetes Care 1990; 13 (Suppl. 4): 1186-90.
32. Warren SE, O'Connor DT. Does a renal vasodilator system mediate racial differences in essential hypertension? Am J Med 1980; 69: 425-9.
33. Pugh JA, Stern MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. Am J Epidemiol 1988; 127: 135-44.
34. Pasinski R, Pasinski M. End-stage renal disease among the Zuni Indians: 1973-1983. Arch Intern Med 1987; 147: 1093-6.
35. Newman JM, Marfin AA, Eggers PW, Helgerson SD. End state renal disease among Native Americans, 1983-86. Am J Public Health 1990; 80: 318-9.
36. Knowler WC, Bennett PH, Nelson RG. Prediabetic blood pressure predicts albuminuria after development of NIDDM. Abstract. Diabetes 1988; 37 (Suppl. 1): 120a.
37. Ballard DJ, Humphrey LL, Melton LJ III et al. Epidemiology of persistent proteinuria in type II diabetes mellitus. Diabetes 1988; 37: 405-12.
38. Rostand SG. Letter. N Engl J Med 1990; 322: 1009-10.
39. Gold CH, Isaacson C, Levin J. The pathological basis of end-stage renal disease in blacks. S Afr Med J 1982; 61: 263-5.
40. Stewart JH, McCarthy SW, Storey BG, Roberts BA, Gallery E, Mahony JF. Diseases causing end-stage renal failure in New South Wales. Br Med J 1975; 1: 440-3.
41. Kasinath BS, Mujais SK, Spargo BH, Katz AI. Nondiabetic renal disease in patients with diabetes mellitus. Am J Med 1983; 75: 613-7.
42. Seedat YK, Nicker S, Rawat R, Parsoo I. Racial differences in the causes of end-stage renal disease in Natal. S Afr Med J 1984; 65: 956-8.
43. Evanoff GV, Thompson CS, Brown J, Weinman EJ. The effect of dietary protein restriction on the progression of diabetic nephropathy. Arch Intern Med 1987; 147: 492-5
44. Consensus Statement: Preventing the kidney disease of diabetes mellitus: public health perspectives. Am J Kidney Dis 1989; 13: 2-7.
45. Hawthorne VM. Preventing the kidney disease of diabetes mellitus: public health perspectives. Am J Kidney Dis 1989; 13: 1-6.
46. Simonson DC. Etiology and prevalence of hypertension in diabetic patients. Diabetes Care 1988; 11: 821-7.
47. Mimran A, Ribstein J. Diabetic nephropathy in normotensive patients. J Hypertension 1990; 8 (Suppl. 1): S53-60.
48. Mogensen CE. Long-term antihypertensive treatment inhibiting progression of diabetic nephropathy. Br Med J 1982; 285: 685-8.
49. Parving HH, Andersen AR, Smidt UM, Hommel E, Mathiesen ER, Svendsen PA. Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J 1987; 294: 1443-7.
50. Feriozzi S, Pierucci A, Roscia E et al. Angiotensin converting enzyme inhibition delays the progression of chronic renal failure in hypertensive patients with immunoglobulin A nephropathy. J Hypertens 1989; 7: S63-4.
51. Ruilope LM, Miranda B, Morales JM et al. Converting enzyme inhibition in chronic renal failure. Am J Kidney Dis 1989; 13: 120-6.
52. Krolewski AS, Canessa M, Warram JM, Laffel LMB, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988; 318: 140-5.
53. Seaquist ER, Goetz FC, Rich S, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 1989; 320: 1161-5.
54. Hasslacher C, Stech W, Wahl P, Ritz E. Blood pressure and metabolic control as risk factors for nephropathy in type I (insulin-dependent) diabetes. Diabetologia 1985; 28: 6-11.
55. Chase HP, Jackson WE, Hoops SL, Cockerham RS, Archer PG, O'Brien D. Glucose control and the renal and retinal complications of insulin-dependent diabetes. JAMA 1989; 261: 1155-60.
56. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, Hamman RE. Cigarette smoking increases the risk of albuminuria among subjects with type I diabetes. JAMA 1991; 265: 614-7.
57. Stegmayr B, Lithner F. Tobacco and end stage diabetic nephropathy. Br Med J 1987; 295: 581-2.